Biocept Inc 's

• BIOC's Stock Performance relative to its Competitors

Caredx Inc Share Performance +162.85% This Year

Caredx Inc Profile Caredx Inc is a precision medicine company with a business model focused on transplant diagnostics. They develop and commercialize non-invasive tests to identify and monitor organ transplant rejection. By offering innovative solutions and services in the transplant field, Caredx Inc aims to improve outcomes for patients and provide healthcare professionals with valuable information to guide treatment decisions. More about Caredx Inc 's Market Share

Fulgent Genetics Inc Share Performance +4.28% Over The Past 5 Days

Fulgent Genetics Inc Profile Fulgent Genetics Inc is a genetic testing company that offers comprehensive, flexible, and affordable genetic testing solutions for various applications, including clinical diagnostics, carrier screening, and genetic research. More about Fulgent Genetics Inc 's Market Share

Guardant Health Inc Share Performance +61.07% This Year

Guardant Health Inc Profile Guardant Health Inc's business model revolves around providing advanced genomic testing services for cancer patients. It specializes in developing liquid biopsy tests that analyze circulating tumor DNA (ctDNA) in the blood. These tests help in early cancer detection, treatment selection, and monitoring of cancer progression. Guardant Health Inc collaborates with healthcare providers, pharmaceutical companies, and researchers to provide these innovative tests and contribute to the advancement of precision medicine in oncology. More about Guardant Health Inc 's Market Share

Grail Inc Share Performance -10.99% This Year

Grail Inc Profile The company develops a blood test that detects multiple cancers at an early stage by analyzing DNA methylation patterns. More about Grail Inc 's Market Share

Myriad Genetics Inc Share Performance -3.85% 30 Days

Myriad Genetics Inc Profile Myriad Genetics Inc's business model revolves around providing molecular diagnostic testing services and developing innovative precision medicine solutions that help identify and personalize treatment options for patients across various medical specialties. More about Myriad Genetics Inc 's Market Share

Sources: Biocept Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, September 8, 2026 9:43 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Biocept Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.